Australia to provide $100 million for Cancer medication

[annie]

Australia to provide $100 million for Cancer medication
Source: Government of Australia Posted on: 11th October 2009
http://thegovmonitor.com/health/austral ... -9477.html
Cita:
"Over the next four years more than a thousand people suffering from multiple myeloma, a type of blood cancer, will benefit from a Rudd Government decision to list lenalidomide (Revlimid®) on the Pharmaceutical Benefits Scheme (PBS) from 1 November 2009. It will also be added to the Repatriation Pharmaceutical Benefits Scheme (RPBS).

Patients who receive lenalidomide (in combination with dexamethasone) can expect, on average, an 11-month extension of reasonable quality life. About 1,200 people a year are diagnosed with multiple myeloma.

Multiple myeloma is the second most common type of cancer of bone marrow. It damages a patient’s bones, resulting in pain, fractures and high blood calcium levels. Multiple myeloma can be controlled with treatment but long term cure is currently unlikely.

The listing of lenalidomide will cost an estimated $104 million between 2009-10 and 2012-13.

The listing of new medicines such as lenalidomide can occur because the Government is committed to maintaining the long-term sustainability of the PBS.

To assist in maintaining the sustainability of the PBS, the Government will introduce cost recovery of the PBS evaluation and listing process from 1 January 2010.

From this date, fees will be payable by pharmaceutical companies for submissions lodged with the Pharmaceutical Benefits Advisory Committee (PBAC) to recover the costs of evaluating a medication before it can be listed on the PBS.

The Government remains committed to maintaining the independence of the PBAC. The PBS evaluation process will not be altered by this measure.

Patients will not need to pay any more than the existing copayments for any PBS-listed medicines or vaccines, of $32.90 for general patients and $5.30 for concessional patients.

The Government has also taken steps to ensure that access to medicines for small patient population groups is maintained.

Topics: Australia, benefits, blood cancer, bone marrow cancer, cancer, dexamethasone, Governance, health care, Health Care, healthcare, lenalidomide, medication, medicine, PBS, Pharmaceutical Benefits Scheme, quality of life, RPBS, Rudd Government"
Fin de la cita.
http://thegovmonitor.com/health/austral ... -9477.html
Traductor google para traducir el articulo en castellano:

http://translate.google.com/?hl=es#

Saludos

[fercu]

Hola a tod@s:

Este link es del articulo de Annie traducido:
http://translate.google.es/translate?js ... ry_state0=
Abrazos fercu y mary